Resultados de la búsqueda 161-170 of 11170 for weakened immune system

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This clinical trial studies the effect of short-term (acute) and long-term (chronic) exercise on immune ... system of indolent NHL and CLL patients, delay ...

2. Cirugía - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This clinical trial studies the effect of short-term (acute) and long-term (chronic) exercise on immune ... system of indolent NHL and CLL patients, delay ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Information learned from this study may help researchers determine whether a particular exercise regimen can be used to strengthen the immune system of indolent ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    ... system tumors. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in ...